Literature DB >> 2590534

B cell associated monoclonal antibody L26 may occasionally label T cell lymphomas.

S J Hamilton-Dutoit1, G Pallesen.   

Abstract

Monoclonal antibody L26 has been shown to be a very sensitive marker for B lymphocytes in formalin-fixed, paraffin-embedded tissue. Most studies have found that the antibody is also highly specific for B cells, although a few examples of L26-positive T cell lymphoma (TCL) have been reported. We have studied L26 reactivity in 50 TCLs (all previously extensively immunophenotyped on frozen sections) and found positive labelling in 4 cases (3 pleomorphic, medium and large cell type with surface membrane staining; 1 T-anaplastic large cell type with cytoplasmic staining). The finding that L26 may give surface labelling in occasional TCLs (particularly of the pleomorphic, medium and large cell type) indistinguishable from that seen in B cell lymphomas emphasises the importance of always using diagnostic MAbs in combination if the risk of misinterpretation of lymphoma cell lineage is to be minimised.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2590534     DOI: 10.1111/j.1699-0463.1989.tb00514.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  3 in total

Review 1.  CD20 positive T cell lymphoma: is it a real entity?

Authors:  T Sun; A Akalin; M Rodacker; T Braun
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

2.  CD20 Positive T Cell Lymphoma Involvement of Skin.

Authors:  Ki Yeol Lee; Su Young Jeon; Jin Woo Hong; Young Hun Kim; Ki Hoon Song; Ki Ho Kim
Journal:  Ann Dermatol       Date:  2011-11-03       Impact factor: 1.444

Review 3.  CD20-positive NK/T-cell lymphoma with indolent clinical course: report of case and review of literature.

Authors:  Qing-ping Jiang; Shao-yan Liu; Yue-xin Yang; Xue-xian Tan; Juan Peng; Zhong-tang Xiong; Zhi Li
Journal:  Diagn Pathol       Date:  2012-10-02       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.